Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161865109> ?p ?o ?g. }
- W3161865109 endingPage "498" @default.
- W3161865109 startingPage "487" @default.
- W3161865109 abstract "Eczema or atopic dermatitis (AD) is a chronically relapsing dermatosis characterized by pruritus and a significant impact on the quality of life.The authors undertook a structured search of peer-reviewed research articles from PubMed and Google Scholar. Recent and up-to-date studies relevant to the topic were included.This report overviews current treatment and experimental drug for AD. Topical agents including topical phosphodiesterase E4 (PDE4) inhibitors such as crisaborole are efficacious in the treatment of AD with few side effects. Monoclonal antibodies such as dupilumab given subcutaneously are efficacious for more severe disease. Systemic treatment can ameliorate symptoms in severe and recalcitrant AD. New systemic treatment includes several traditional herbal formulations that have undergone clinical trials using modern research methodology to determine their efficacy and safety. AD is associated with many complicating psychosocial issues. Often suboptimal efficacy is due to unrealistic expectations and poor compliance making treatment difficult in spite of effective treatment and efforts in drug discovery. Randomized trials have shown that novel topical and subcutaneous medications are safe and efficacious. Regarding herbs, a methodology for the investigation of herbal medications is often flawed and scientific evidence is lacking. Experimental drugs include various biologics, PDE4 and JAK inhibitors in topical, oral, subcutaneous or intravenous forms are in various phases of trials.Many novel medications demonstrate efficacy for AD. Experimental drugs include various biologics, PDE4 and JAK inhibitors are in various phases of trials." @default.
- W3161865109 created "2021-05-24" @default.
- W3161865109 creator A5013427107 @default.
- W3161865109 creator A5027721931 @default.
- W3161865109 creator A5065329974 @default.
- W3161865109 date "2021-05-01" @default.
- W3161865109 modified "2023-10-13" @default.
- W3161865109 title "Experimental Drugs with the Potential to Treat Atopic Eczema" @default.
- W3161865109 cites W121146899 @default.
- W3161865109 cites W1494871581 @default.
- W3161865109 cites W150232649 @default.
- W3161865109 cites W1527957830 @default.
- W3161865109 cites W1863548789 @default.
- W3161865109 cites W1894106475 @default.
- W3161865109 cites W1916016072 @default.
- W3161865109 cites W1963571963 @default.
- W3161865109 cites W1964449771 @default.
- W3161865109 cites W1969725546 @default.
- W3161865109 cites W1973874699 @default.
- W3161865109 cites W1974875896 @default.
- W3161865109 cites W1976416025 @default.
- W3161865109 cites W1979758192 @default.
- W3161865109 cites W1980744320 @default.
- W3161865109 cites W1988988173 @default.
- W3161865109 cites W1989744296 @default.
- W3161865109 cites W1994943033 @default.
- W3161865109 cites W1996609353 @default.
- W3161865109 cites W1999639094 @default.
- W3161865109 cites W2005039152 @default.
- W3161865109 cites W2005630031 @default.
- W3161865109 cites W2008251101 @default.
- W3161865109 cites W2008303762 @default.
- W3161865109 cites W2010525321 @default.
- W3161865109 cites W2010624460 @default.
- W3161865109 cites W2017080463 @default.
- W3161865109 cites W2019286335 @default.
- W3161865109 cites W2020335571 @default.
- W3161865109 cites W2022518007 @default.
- W3161865109 cites W2028590815 @default.
- W3161865109 cites W2034703215 @default.
- W3161865109 cites W2036106065 @default.
- W3161865109 cites W2037641643 @default.
- W3161865109 cites W2037815074 @default.
- W3161865109 cites W2041332288 @default.
- W3161865109 cites W2053396373 @default.
- W3161865109 cites W2054968345 @default.
- W3161865109 cites W2056207075 @default.
- W3161865109 cites W2062069212 @default.
- W3161865109 cites W2062702626 @default.
- W3161865109 cites W2065178330 @default.
- W3161865109 cites W2066224059 @default.
- W3161865109 cites W2067548168 @default.
- W3161865109 cites W2068176013 @default.
- W3161865109 cites W2070316318 @default.
- W3161865109 cites W2070487166 @default.
- W3161865109 cites W2072961964 @default.
- W3161865109 cites W2074019883 @default.
- W3161865109 cites W2081364433 @default.
- W3161865109 cites W2086484740 @default.
- W3161865109 cites W2087672673 @default.
- W3161865109 cites W2088035923 @default.
- W3161865109 cites W2093530371 @default.
- W3161865109 cites W2095488032 @default.
- W3161865109 cites W2096493860 @default.
- W3161865109 cites W2102533578 @default.
- W3161865109 cites W2104283436 @default.
- W3161865109 cites W2114200145 @default.
- W3161865109 cites W2114230248 @default.
- W3161865109 cites W2117010720 @default.
- W3161865109 cites W2120246175 @default.
- W3161865109 cites W2120966332 @default.
- W3161865109 cites W2123554401 @default.
- W3161865109 cites W2128472414 @default.
- W3161865109 cites W2128883495 @default.
- W3161865109 cites W2131656488 @default.
- W3161865109 cites W2136651579 @default.
- W3161865109 cites W2141458028 @default.
- W3161865109 cites W2142327072 @default.
- W3161865109 cites W2145297425 @default.
- W3161865109 cites W2148435201 @default.
- W3161865109 cites W2150513168 @default.
- W3161865109 cites W2152243121 @default.
- W3161865109 cites W2167235221 @default.
- W3161865109 cites W2171343997 @default.
- W3161865109 cites W2171835211 @default.
- W3161865109 cites W2174132185 @default.
- W3161865109 cites W2182663550 @default.
- W3161865109 cites W2182734448 @default.
- W3161865109 cites W2184069226 @default.
- W3161865109 cites W2186458856 @default.
- W3161865109 cites W2276335262 @default.
- W3161865109 cites W2313828678 @default.
- W3161865109 cites W2387317055 @default.
- W3161865109 cites W2398734429 @default.
- W3161865109 cites W2410446282 @default.
- W3161865109 cites W2418104554 @default.
- W3161865109 cites W2418638731 @default.
- W3161865109 cites W2418912185 @default.